This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2010-2013.
Location History:
- Kapasan, IN (2010)
- Chittorgarh, IN (2013)
Company Filing History:
Years Active: 2010-2013
Title: Lalit Kumar Baregama: Innovator in Phosphodiesterase Inhibitors
Introduction
Lalit Kumar Baregama is a notable inventor based in Chittorgarh, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of phosphodiesterase inhibitors. With a total of 2 patents, his work focuses on addressing various central nervous system diseases and inflammatory conditions.
Latest Patents
His latest patents include innovative compounds such as Pyrazolo (3, 4-B) pyridine derivatives, which serve as phosphodiesterase type 4 and type 7 inhibitors. These compounds are designed to treat and prevent a range of diseases, including multiple sclerosis, autoimmune disorders, and various inflammatory diseases. Another significant patent involves substituted indazoles that act as selective inhibitors of phosphodiesterase type IV, targeting conditions like asthma, arthritis, and chronic obstructive pulmonary disease (COPD).
Career Highlights
Lalit Kumar Baregama is currently associated with Ranbaxy Laboratories, Inc., where he continues to advance his research and development efforts. His work has the potential to impact the treatment of numerous health conditions, making him a valuable asset in the pharmaceutical industry.
Collaborations
He collaborates with esteemed colleagues such as Venkata Poornapragnacharyulu Palle and Sarala Balachandran, contributing to a dynamic research environment that fosters innovation.
Conclusion
Lalit Kumar Baregama's contributions to the field of phosphodiesterase inhibitors highlight his commitment to advancing medical science. His innovative patents and collaborative efforts position him as a key figure in the pharmaceutical landscape.